false
0001735948
A6
0001735948
2024-02-22
2024-02-22
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 22, 2024
GREENBROOK TMS INC.
(Exact name of registrant as specified in its
charter)
Ontario |
|
001-40199 |
|
98-1512724 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission
File No.) |
|
(IRS Employee
Identification No.) |
890 Yonge Street, 7th Floor
Toronto, Ontario Canada
M4W 3P4
(Address of Principal Executive Offices)
(866) 928-6076
(Registrant’s telephone number, including
area code)
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class |
|
Trading
Symbol(s) |
|
Name of Each Exchange
on Which Registered |
Common Shares, without par value |
|
GBNH |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
| Item 3.01 | Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
On
February 22, 2024, Greenbrook TMS Inc. (the “Company”) received the final delisting notice from the Listing
Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) due to the continued failure to satisfy either
the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) or the minimum stockholders’ equity requirements
in Nasdaq Listing Rule 5550(b). Nasdaq has notified the Company that trading of its common shares (the “Common Shares”)
will be suspended as of the open of trading on February 26, 2024. After careful consideration, the Company determined that it was in the
overall best interests of the Company not to appeal the decision.
The Company intends to quote
the Common Shares on OTC Markets as soon as practicable following the suspension of its Common Shares on Nasdaq.
Nasdaq
has informed the Company that it will file a Form 25-NSE with the U.S. Securities and Exchange Commission (the “SEC”),
which will remove the Company’s Common Shares from listing on Nasdaq and registration under Section 12(b) of the U.S. Securities
Exchange Act of 1934.
Certain statements contained
in this Current Report on Form 8-K, including statements relating to the Company’s intention to quote the Common Shares on OTC Markets,
may constitute “forward-looking information” within the meaning of applicable securities laws in Canada and “forward-looking
statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 (collectively, “forward-looking
information”). Forward-looking information may relate to the Company’s future financial and liquidity outlook and anticipated
events or results and may include information regarding the Company’s business, financial position, results of operations, business
strategy, growth plans and strategies, technological development and implementation, budgets, operations, financial results, taxes, dividend
policy, plans and objectives. In some cases, forward-looking information can be identified by the use of forward-looking terminology such
as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an
opportunity exists”, “budget”, “scheduled”, “estimates”, “outlook”, “forecasts”,
“projection”, “prospects”, “strategy”, “intends”, “anticipates”, “does
not anticipate”, “believes”, or variations of such words and phrases or statements that certain actions, events or results
“may”, “should”, “could”, “would”, “might”, “will”, “will
be taken”, “occur” or “be achieved”. In addition, any statements that refer to expectations, intentions,
projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking
information are not facts but instead represent management’s expectations, estimates and projections regarding future events or
circumstances.
Forward-looking information
is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date
of this Current Report on Form 8-K, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause
the actual results, level of activity, performance or achievements or future events or developments to differ materially from those expressed
or implied by the forward-looking statements, including, without limitation: macroeconomic factors such as inflation and recessionary
conditions, substantial doubt regarding the Company’s ability to continue as a going concern due to recurring losses from operations;
inability to increase cash flow and/or raise sufficient capital to support the Company’s operating activities and fund its cash
obligations, repay indebtedness and satisfy the Company’s working capital needs and debt obligations; prolonged decline in the price
of the Common Shares reducing the Company’s ability to raise capital; inability to satisfy debt covenants under the Company’s
credit facility with affiliates of Madryn Asset Management, LP (the “Credit Facility”) and the potential acceleration
of indebtedness; risks related to the resolution of the Company’s ongoing litigation with Benjamin Klein and compliance with the
terms of their settlement agreement; risks related to the ability to continue to negotiate amendments to the Credit Facility to prevent
a default; risks relating to the Company’s ability to deliver and execute on the previously-announced restructuring plan (the “Restructuring
Plan”) and the possible failure to complete the Restructuring Plan on terms acceptable to the Company or its suppliers (including
Neuronetics, Inc.), or at all; risks relating to maintaining an active, liquid and orderly trading market for Common Shares as a result
of the Company’s forthcoming delisting from Nasdaq; risks relating to the Company’s ability to realize expected cost-savings
and other anticipated benefits from the Restructuring Plan; risks related to the Company’s negative cash flows, liquidity and its
ability to secure additional financing; increases in indebtedness levels causing a reduction in financial flexibility; inability to achieve
or sustain profitability in the future; inability to secure additional financing to fund losses from operations and satisfy the Company’s
debt obligations; risks relating to strategic alternatives, including restructuring or refinancing of the Company’s debt, seeking
additional debt or equity capital, reducing or delaying the Company’s business activities and strategic initiatives, or selling
assets, other strategic transactions and/or other measures, including obtaining bankruptcy protection, and the terms, value and timing
of any transaction resulting from that process; claims made by or against the Company, which may be resolved unfavorably to us; risks
relating to the Company’s dependence on Neuronetics, Inc. as its exclusive supplier of TMS devices. Additional risks and uncertainties
are discussed in the Company’s materials filed with the Canadian securities regulatory authorities and the SEC from time to time,
available at www.sedarplus.ca and www.sec.gov, respectively. These factors are not intended to represent a complete list of the factors
that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and
assumptions will prove to be correct. The forward-looking statements contained in this Current Report on Form 8-K are made as of the date
of this report, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information,
or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required
by law.
| Item 7.01 | Regulation FD Disclosure. |
On
February 23, 2024, the Company issued a press release announcing that it had received the final delisting notice from Nasdaq and the press
release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The
information contained in this Current Report on Form 8-K under Item 7.01, including the attached Exhibit 99.1, is being furnished pursuant
to Item 7.01 of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information contained
in this Current Report on Form 8-K under Item 7.01, shall not be incorporated by reference into any filing under the Securities Act of
1933, as amended, or any filing under the Exchange Act, whether made before or after the date hereof, except as shall be expressly set
forth by specific reference in such a filing.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: February 23, 2024
|
Greenbrook TMS Inc. |
|
|
|
|
By: |
/s/ Bill Leonard |
|
Name: |
Bill Leonard |
|
Title: |
President & Chief Executive Officer |
Exhibit 99.1
GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ
February 23, 2024 – Toronto, ON –
Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company”) today announced receipt of the
final delisting notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) due to
the continued failure to satisfy either the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) or the minimum
stockholders’ equity requirements in Nasdaq Listing Rule 5550(b). Nasdaq has notified the Company that trading of its common shares
(the “Common Shares”) will be suspended as of the open of trading on February 26, 2024. After careful consideration,
the Company determined that it was in the overall best interests of the Company not to appeal the decision.
The Company intends to quote the Common Shares
on OTC Markets as soon as practicable following the suspension of its Common Shares on Nasdaq.
Nasdaq has informed the Company that it will file
a Form 25-NSE with the U.S. Securities and Exchange Commission (the “SEC”), which will remove the Company’s Common
Shares from listing on Nasdaq and registration under Section 12(b) of the U.S. Securities Exchange Act of 1934.
About Greenbrook TMS Inc.
Operating through 130 Company-operated treatment
centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy and Spravato® (esketamine
nasal spray), FDA-cleared, non-invasive therapies for the treatment of Major Depressive Disorder (“MDD”) and other
mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known
to be directly associated with mood regulation. Spravato® is offered to treat adults with treatment-resistant depression and depressive
symptoms in adults with MDD with suicidal thoughts or actions. Greenbrook has provided more than 1.3 million treatments to over 40,000
patients struggling with depression.
For further information please contact:
Glen Akselrod
Investor Relations
Greenbrook TMS Inc.
Contact Information:
investorrelations@greenbrooktms.com
1-855-797-4867
Cautionary Note Regarding Forward-Looking Information
Certain statements contained in this press release,
including statements relating to the Company’s intention to quote the Common Shares on OTC Markets, may constitute “forward-looking
information” within the meaning of applicable securities laws in Canada and “forward-looking statements” within the
meaning of the United States Private Securities Litigation Reform Act of 1995 (collectively, “forward-looking information”).
Forward-looking information may relate to the Company’s future financial and liquidity outlook and anticipated events or results
and may include information regarding the Company’s business, financial position, results of operations, business strategy, growth
plans and strategies, technological development and implementation, budgets, operations, financial results, taxes, dividend policy, plans
and objectives. Particularly, information regarding anticipated listings may be forward-looking information. In some cases, forward-looking
information can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects”
or “does not expect”, “is expected”, “an opportunity exists”, “budget”, “scheduled”,
“estimates”, “outlook”, “forecasts”, “projection”, “prospects”, “strategy”,
“intends”, “anticipates”, “does not anticipate”, “believes”, or variations of such words
and phrases or statements that certain actions, events or results “may”, “should”, “could”, “would”,
“might”, “will”, “will be taken”, “occur” or “be achieved”. In addition, any
statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking
information. Statements containing forward-looking information are not facts but instead represent management’s expectations, estimates
and projections regarding future events or circumstances.
Forward-looking information is necessarily based
on a number of opinions, assumptions and estimates that, while considered reasonable by the Company as of the date of this press release,
are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity,
performance or achievements or future events or developments to differ materially from those expressed or implied by the forward-looking
statements, including, without limitation: macroeconomic factors such as inflation and recessionary conditions, substantial doubt regarding
the Company’s ability to continue as a going concern due to recurring losses from operations; inability to increase cash flow and/or
raise sufficient capital to support the Company’s operating activities and fund its cash obligations, repay indebtedness and satisfy
the Company’s working capital needs and debt obligations; prolonged decline in the price of the Common Shares reducing the Company’s
ability to raise capital; inability to satisfy debt covenants under the Company’s credit facility with affiliates of Madryn Asset
Management, LP (the “Credit Facility”) and the potential acceleration of indebtedness; risks related to the resolution
of the Company’s ongoing litigation with Benjamin Klein and compliance with the terms of their settlement agreement; risks related
to the ability to continue to negotiate amendments to the Credit Facility to prevent a default; risks relating to the Company’s
ability to deliver and execute on the previously-announced restructuring plan (the “Restructuring Plan”) and the possible
failure to complete the Restructuring Plan on terms acceptable to the Company or its suppliers (including Neuronetics, Inc.), or at all;
risks relating to maintaining an active, liquid and orderly trading market for Common Shares as a result of the Company’s forthcoming
delisting from Nasdaq; risks relating to the Company’s ability to realize expected cost-savings and other anticipated benefits from
the Restructuring Plan; risks related to the Company’s negative cash flows, liquidity and its ability to secure additional financing;
increases in indebtedness levels causing a reduction in financial flexibility; inability to achieve or sustain profitability in the future;
inability to secure additional financing to fund losses from operations and satisfy the Company’s debt obligations; risks relating
to strategic alternatives, including restructuring or refinancing of the Company’s debt, seeking additional debt or equity capital,
reducing or delaying the Company’s business activities and strategic initiatives, or selling assets, other strategic transactions
and/or other measures, including obtaining bankruptcy protection, and the terms, value and timing of any transaction resulting from that
process; claims made by or against the Company, which may be resolved unfavorably to us; risks relating to the Company’s dependence
on Neuronetics, Inc. as its exclusive supplier of TMS devices. Additional risks and uncertainties are discussed in the Company’s
materials filed with the Canadian securities regulatory authorities and the SEC from time to time, available at www.sedarplus.ca and www.sec.gov,
respectively. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these
factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking
statements contained in this press release are made as of the date of this press release, and the Company expressly disclaims any obligation
to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a
result of new information, future events or otherwise, except as required by law.
v3.24.0.1
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionISO 3166-1 alpha-2 country code.
+ References
+ Details
Name: |
dei_EntityAddressCountry |
Namespace Prefix: |
dei_ |
Data Type: |
dei:countryCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Grafico Azioni Greenbrook TMS (NASDAQ:GBNH)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Greenbrook TMS (NASDAQ:GBNH)
Storico
Da Dic 2023 a Dic 2024